Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension

International Journal of Pharmaceutics

Volumn 441, Issue 1-2, 2013, Pages 227-233

  Guo, Jing Jing ^a   Yue, Peng Fei ^b,c   Lv, Jun Lan ^a   Han, Jin ^a   Fu, Shan Shan ^a   Jin, Shi Xiao ^a   Jin, Shi Ying ^a   Yuan, Hai Long ^a  

^a BEIJING 302 HOSPITAL   (China)

^b JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Activity assay; Bioavailability; Dissolution; Herpetrione; Nanosuspension

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HERPETRIONE; UNCLASSIFIED DRUG; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG SOLUBILITY; DRY POWDER; FREEZE DRYING; GASTROINTESTINAL TRACT; HEPATITIS B VIRUS; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRESSURE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUSPENSION; X RAY DIFFRACTION; ZETA POTENTIAL;

ANIMALS; ANTIVIRAL AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CUCURBITACEAE; DNA, VIRAL; DRUG COMPOUNDING; FREEZE DRYING; FURANS; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; RATS; RATS, WISTAR; SOLUBILITY; SUSPENSIONS; X-RAY DIFFRACTION;

EID: 84872768214     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.11.039     Document Type: Article

References (32)

1. H.S.M. Ali, P. York, and N. Blagden Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors Int. J. Pharm. 375 2009 107 113
2. Chinese Pharmacopoeia Committee Drug Standard of Ministry of Public Healthy of People's Republic of China, Tibetan Medicine 1995 Chemical Industry Press Beijing p. 133
3. S. Gramdorf, S. Hermann, A. Hentschel, K. Schrader, R.H. Muller, M. KumpugdeeVollrath, and M. Kraume Crystallized miniemulsions: influence of operating parameters during high-pressure homogenization on size and shape of particles Colloids Surf. A 331 2008 108 113
4. Y. Han, H. Yuan, Y. Liu, and Y. Zhao Experimental research on in vitro inhibitory effect of Ganneng Dripping Pill on HBV Chin. Tradit. Herb. Drugs 36 2005 169 171
5. Y. Han, Z. Li, H. Yuan, Y. Liu, and Y. Zhao Curative effect of Ganneng Dripping Pill on ducks in vivo transfected by DHBV Chin. J. Exp. Tradit. Med. Form. 12 2006 42 43
6. J. Hecq, M. Deleers, D. Fanara, H. Vranckx, P. Boulanger, S. Le Lamer, and K. Amighi Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base Eur. J. Pharm. Biopharm. 64 2006 360 368
7. T. Io, T. Fukami, K. Yamamoto, T. Suzuki, J.D. Xu, K. Tomono, and A. Ramamoorthy Homogeneous nanoparticles to enhance the efficiency of a hydrophobic drug, antihyperlipidemic probucol, characterized by solid-state NMR Mol. Pharm. 7 2010 299 305
8. C. Jacobs, O. Kayser, and R.H. Müller Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide Int. J. Pharm. 196 2000 161 164
9. T. Jung, W. Kamm, A. Breitenbach, E. Kaiserling, J.X. Xiao, and T. Kissel Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur. J. Pharm. Biopharm. 50 2000 147 160
10. P. Jani, G.W. Halbert, J. Langridge, and A.T. Florence The uptake and translocation of latex nanospheres and microspheres after oral administration to rats J. Pharm. Pharmacol. 41 1989 809 812
11. P. Jani, G.W. Halbert, J. Langridge, and A.T. Florence Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency J. Pharm. Pharmacol. 42 1990 821 826
12. J.U.A.H. Junghanns, and R.H. Muller Nanocrystal technology, drug delivery and clinical applications Int. J. Nanomed. 3 2008 295 309
13. M. Kaouadji, B.J. Favre, and A.M. Mariotte Herpetal, a benzofuran isolated from Herpetospermun caudigerum Phytochemistry 17 1978 2134 2135
14. M. Kaouadji, B.J. Favre, and A.M. Mariotte Herpetriol and herpetetrol, lignoids isolated from Herpetospemun caudigerum Bioscience 34C 1979 1129 1132
15. M. Kaouadji, and B.J. Favre Herpetradione, a new lignoid tetramer isolated from Herpetospermum caudigerum Wall Tetrahedron Lett. 25 1984 5135 5136
16. M. Kaouadji, and B.J. Favre Herpepentol, a new lignoid pentamer Tetrahedron Lett. 25 1984 5137 5138
17. M. Kaouadji, B.J. Favre, and S. Francoise Herpetetrone, another tetrameric lignoid from Herpetospermum caudigerum seeds J. Nat. Prod. 50 1987 1089 1093
18. F. Lai, C. Sinico, G. Ennas, F. Marongiu, G. Marongiu, and A.M. Fadda Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour Int. J. Pharm. 373 2009 124 132
19. R.H. Müller, and B.H.L. Bohn Nanosuspensions R.H. Müller, B.H.L. Bohn, S. Benita, Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs 1998 Medpharm Scientific Publishers Stuttgart
20. R.H. Müller, and A. Akkar Drug nanocrystals of poorly soluble drugs Encycl. Nanosci. Nanotechnol. 2 2004 627 638
21. M. Mosharraf, and C. Nyström The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs Int. J. Pharm. 122 1995 35 47
22. R.H. Muller, C. Jacobs, and O. Kayser Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future Adv. Drug Deliv. Rev. 47 2001 3 19
23. V.B. Patravale, A.A. Date, and R.M. Kulkarni Nanosuspensions: a promising drug delivery strategy J. Pharm. Pharmacol. 56 2004 827 840
24. X. Pu, J. Sun, Y. Wang, X. Liu, P. Zhang, X. Tang, W. Pan, J. Han, and Z. He Development of a chemically stable 10-hydroxycamptothecin nanosuspensions Int J. Pharm. 379 2009 167 173
25. B.E. Rabinow Nanosuspensions in drug delivery Nat. Rev. Drug Discov. 3 2004 785 796
26. M. Sarkari, J. Brown, X. Chen, S. Swinnea, R.O. Williams, and K.P. Johnston Enhanced drug dissolution using evaporative precipitation into aqueous solution Int. J. Pharm. 243 2002 17 31
27. M.A. Sells, M.L. Chen, and G. Acs Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA Proc. Natl. Acad. Sci. U.S.A. 84 1987 1005 1008
28. B. Van Eerdenbrugh, G. Van den Mooter, and P. Augustijns Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products Int. J. Pharm. 364 2008 64 75
29. Y. Wang, D. Zhang, Z. Liu, G. Liu, C. Duan, L. Jia, F. Feng, X. Zhang, Y. Shi, and Q. Zhang In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery Nanotechnology 21 2010 155104
30. Z. Wu The Flora of Xizang 1985 Science Press Beijing p. 537
31. Yuan, H., Guo, J., Li, X., Lv, J., 2011. Preparation and application of herperione and its capsule, China, 201110072191.9 (24.03.11).
32. J. Zhong, Z. Shen, Y. Yang, and J. Chen Preparation and characterization of uniform nanosized cephradine by combination of reactive precipitation and liquid anti-solvent precipitation under high gravity environment Int. J. Pharm. 301 2005 283 293